(Q44381786)

2 December 2017

title

Impact of prior immunological exposure on vaccine delivery by Salmonella enterica serovar Typhimurium (English)

1 reference

2 December 2017

0 references

Michelle E Gahan

1

0 references

Richard A. Strugnell

object named as

Richard A Strugnell

series ordinal

5

0 references

Odilia L C Wijburg

series ordinal

3

object named as

Odilia L C Wijburg

1 reference

2 December 2017

4

Steven L Wesselingh

1 reference

2 December 2017

Diane E Webster

2

1 reference

2 December 2017

language of work or name

English

0 references

publication date

11 October 2008

1 reference

2 December 2017

1 reference

2 December 2017

volume

26

1 reference

2 December 2017

issue

49

1 reference

2 December 2017

page(s)

6212-6220

1 reference

Bacteria as DNA vaccine carriers for genetic immunization

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

The use of live attenuated bacteria as a delivery system for heterologous antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Advances in the development of bacterial vector technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Risk of transmission of hepatitis B virus through childhood immunization in northwestern China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Vector priming reduces the immunogenicity of Salmonella-based vaccines in Nramp1+/+ mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Vector-primed mice display hypo-responsiveness to foreign antigen presented by recombinant Salmonella regardless of the route of delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Long-term immunological memory induced by recombinant oral Salmonella vaccine vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

The Antibody Response to an Oral Ty21a-Based Typhoid-Cholera Hybrid Is Unaffected by Prior Oral Vaccination with Ty21a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

7 January 2021

Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile Escherichia coli enterotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

7 January 2021

Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

7 January 2021

Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.060

7 January 2021

10.1016/J.VACCINE.2008.09.060

Identifiers

DOI

1 reference

2 December 2017

1 reference